Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in combination with platinum-based doublet chemotherapy (PT-DC) in advanced non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Antonia, S. J.; Brahmer, J. R.; Gettinger, S.; Chow, L. Q.; Juergens, R.; Shepherd, F. A.; Laurie, S. A.; Gerber, D. E.; Goldman, J.; Shen, Y.; Harbison, C.; Chen, A. C.; Borghaei, H.; Rizvi, N. A.
Abstract Title: Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in combination with platinum-based doublet chemotherapy (PT-DC) in advanced non-small cell lung cancer (NSCLC)
Meeting Title: 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 90
Issue: 5 Suppl.
Meeting Dates: 2014 Oct 30-Nov 1
Meeting Location: Chicago, IL
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2014-11-15
Start Page: S2
Language: English
ACCESSION: WOS:000346413500004
PROVIDER: wos
DOI: 10.1016/j.ijrobp.2014.08.024
Notes: Meeting Abstract: 3 -- Chicago Multidisciplinary Symposium in Thoracic Oncology -- OCT 30-NOV 01, 2014 -- Chicago, IL -- 5 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Naiyer A Rizvi
    166 Rizvi